CIK 0000946644
- Non-accelerated filer
- Smaller reporting company
AIM ImmunoTech Inc.
Sign in to watch- Ticker
- AIM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 520845822
- Phone
- +1 352-448-7797
- Business address
- 2117 SW HIGHWAY 484, OCALA, FL, 32801
- Former names
- AIM ImmunoTech Inc., HEMISPHERX BIOPHARMA INC
- 4 Grant or award CEO, President acquired 21,552 shares (grant or award)
- 4 Grant or award CEO, President acquired 11,811 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 19,379 shares (grant or award)
- 4 Grant or award CEO & President acquired 11,627 shares (grant or award)
- 4 Grant or award CEO & President acquired 11,194 shares (grant or award)
- 4 Grant or award CEO & President acquired 10,204 shares (grant or award)
- 4 Grant or award CEO & President acquired 9,146 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO & President bought 15,625 shares at $1.92 ($30,000)
- 4 Open-market buy Director bought 10,638 shares at $2.35 ($24,999)
- 4 Open-market buy CEO & President bought 11,062 shares at $2.26 ($25,000)
- 4 Open-market buy CEO bought 14,535 shares at $1.72 ($25,000)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO & President bought 12,316 shares at $2.03 ($25,001)
Page 6 of 31 · 615 filings